Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting

NCT06932107 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

518

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Nausea and Vomiting

Interventions

DRUG: Aprepitant Injection
DRUG: Aprepitant Injection Placebo

Sponsor

Qilu Pharmaceutical (Hainan) Co., Ltd.